Parnaby C N, Jenkins J T, Ferguson J C, Williamson B W A
Department of Surgery, Southern General Hospital, Glasgow, Scotland.
Surg Endosc. 2008 May;22(5):1165-72. doi: 10.1007/s00464-008-9775-5. Epub 2008 Feb 21.
In patients with suspected pancreatico-biliary disease, endoscopic retrograde cholangiopancreatography (ERCP) should be reserved for those requiring therapeutic intervention. However, difficulty arises in identifying patients likely to require therapy in the early phase of diagnostic work-up. An algorithm has been developed by the authors based upon prospective assessment of ERCP patients for triage of patients to magnetic resonance cholangiopancreatography (MRCP) or ERCP with suspected pancreatico-biliary disease. We aimed to validate this algorithm in an independent group of patients using a different group of endoscopists blinded to the algorithm.
Patients were stratified into different categories by clinical, ultrasound and liver function test findings. The algorithm stratified patients by the likelihood of therapeutic intervention. The accuracy of the algorithm for a therapeutic outcome was assessed by receiver operator characteristics (ROC) curve analysis.
Hundred and twenty-five consecutive patients (Oct 2005 to July 2006) were prospectively assessed by MRCP or ERCP according to the algorithm, and the outcomes recorded. Fifty-seven patients were triaged to MRCP and 63 patients were triaged to ERCP. A category was not assessable in five patients. Three patients from the MRCP group required subsequent therapeutic ERCP. Diagnostic ERCP was performed in three patients in the ERCP group. ERCP-related complications occurred in four patients. The algorithm performed well in predicting the requirement for intervention as determined by the area under the ROC curve [0.84 (95%CI 0.76-0.92)].
Our study confirms that an algorithm-based approach can reproducibly predict those patients requiring therapeutic biliary intervention.
在疑似胰胆疾病的患者中,内镜逆行胰胆管造影术(ERCP)应仅用于那些需要进行治疗性干预的患者。然而,在诊断检查的早期阶段,识别可能需要治疗的患者存在困难。作者基于对ERCP患者的前瞻性评估开发了一种算法,用于对疑似胰胆疾病的患者进行分流,以决定是进行磁共振胰胆管造影(MRCP)还是ERCP。我们旨在使用一组对该算法不知情的不同内镜医师,在一组独立的患者中验证该算法。
根据临床、超声和肝功能检查结果将患者分为不同类别。该算法根据治疗性干预的可能性对患者进行分层。通过受试者操作特征(ROC)曲线分析评估该算法对治疗结果的准确性。
根据该算法,对连续125例患者(2005年10月至2006年7月)进行了前瞻性的MRCP或ERCP评估,并记录结果。57例患者被分流至MRCP,63例患者被分流至ERCP。5例患者无法进行评估。MRCP组中有3例患者随后需要进行治疗性ERCP。ERCP组中有3例患者进行了诊断性ERCP。4例患者发生了与ERCP相关的并发症。根据ROC曲线下面积[0.84(95%CI 0.76-0.92)]判断,该算法在预测干预需求方面表现良好。
我们的研究证实,基于算法的方法能够可重复地预测那些需要进行治疗性胆道干预的患者。